Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine
Condition: Polio Interventions: Biological: sIPV; Biological: Commercialized sIPV; Biological: Commercialized IPV Sponsors: Jiangsu Province Centers for Disease Control and Prevention; Beijing Minhai Biotechnology Co., Ltd Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Centers for Disease Control and Prevention (CDC) | Polio | Polio Vaccine | Research | Vaccines